CXCR5 and myeloid sarcoma: It was proven that the frequency of circulating CXCR5+PD‐1+ Tfhs was increased in MS patients, whereas the frequency of circulating CXCR5+PD‐1+ FOXP3+CD25+ Tfrs was significantly decreased.